Catalyst Wire Dossier Catalyst Wire Dossier

Pharmaton PHL 00747

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pharmaton PHL 00747, covering 2014-07-08 to 2014-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability of Pharmaton PHL 00747 in Healthy, Young Female Subjects of Child-bearing Potential [Phase 3]

See pricing